financetom
Business
financetom
/
Business
/
Update: Citigroup Shifts Data Overhaul Responsibility to CTO Tim Ryan From COO Anand Selva
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Citigroup Shifts Data Overhaul Responsibility to CTO Tim Ryan From COO Anand Selva
Sep 16, 2024 12:06 PM

10:20 AM EDT, 09/16/2024 (MT Newswires) -- (Updates with Citi response in the fourth paragraph and latest stock movement in the last paragraph.)

Citigroup ( C ) is removing chief operating officer Anand Selva from overseeing a key compliance data overhaul following a $136 million fine this summer for reporting failures, the Financial Times reported Monday, citing four people familiar with the matter.

The task will shift to chief technology officer Tim Ryan, who joined the bank in June, according to the report.

Selva will continue leading broader risk control efforts and back-office operations, the report said. An announcement on the changes is expected Monday, it added.

"COO Anand Selva still remains in charge of the overall Transformation effort," a Citigroup ( C ) spokesman told MT Newswires, adding he has not been removed from the Data work. "He is now co-leading that piece of the Transformation with Tim Ryan, our Head of Technology and Business Enablement."

Citi was fined by the US regulators in July for inaccurately reporting details of loans and was asked to demonstrate it was putting sufficient resources toward those efforts, according to media reports.

Citi shares were up 1.5% in recent early Monday trading.

Price: 58.55, Change: +0.88, Percent Change: +1.53

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Biogen's Motor Neurone Disease Treatment Gets UK Regulator Approval
Biogen's Motor Neurone Disease Treatment Gets UK Regulator Approval
Jul 28, 2025
05:33 AM EDT, 07/28/2025 (MT Newswires) -- Biogen's (BIIB) tofersen, or Qalsody, has received approval from the UK's Medicines and Healthcare Products Regulatory Agency to treat adults with amyotrophic lateral sclerosis associated with a mutation in the superoxide dismutase 1 gene, the agency said Monday. Amyotrophic lateral sclerosis is a progressive condition that impacts nerve cells in the brain and...
BRIEF-Cheetah Mobile To Buy 60.8% Of Ufactory For RMB99.5 Mln
BRIEF-Cheetah Mobile To Buy 60.8% Of Ufactory For RMB99.5 Mln
Jul 28, 2025
July 28 (Reuters) - Cheetah Mobile Inc: * CHEETAH MOBILE TO ACQUIRE CONTROLLING STAKE IN UFACTORY TO ACCELERATE ITS ROBOTICS COMMERCIALIZATION STRATEGY * CHEETAH MOBILE INC - TO BUY 60.8% OF UFACTORY FOR RMB99.5 MILLION Source text: Further company coverage: ...
INmune Bio Rebounds Sharply During After Hours Trading: What's Driving the Surge?
INmune Bio Rebounds Sharply During After Hours Trading: What's Driving the Surge?
Jul 28, 2025
INmune Bio Inc. ( INMB ) stock surged by 24.72% in after-hours trading on Friday. The company announced a novel selective soluble TNF inhibitor, which is likely to have influenced the stock’s performance. Check out the current price of INMB stock here.  What Happened: The stock of the Florida-based biotechnology company closed at $2.71 on Friday, down 2.52%, before rising...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved